Profile of patients with Kaposi's sarcoma (KS) in the era of highly active antiretroviral therapy (HAART).

被引：0
|
作者：
Gallafent, JH
Buskin, S
De Turk, P
Aboulafia, DM
机构：
[1] Univ Washington, Sch Med, Seattle, WA USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] HIV AIDS Epidemiol Program, Seattle, WA USA
[4] Virginia Mason Med Ctr, Dept Hematol & Oncol, Seattle, WA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
997
引用
收藏
页码：280A / 280A
页数：1
相关论文
共 50 条
  • [1] Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy
    Gallafent, JH
    Buskin, SE
    De Turk, PB
    Aboulafia, DM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1253 - 1260
  • [2] Clinical profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent, JH
    Buskin, S
    De Turk, R
    Aboulafia, DM
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S157 - S157
  • [3] Highly active antiretroviral therapy (HAART) is active as anti-Kaposi's sarcoma (KS) therapy: Results of a trial in 53 patients (PTS)
    Vaccher, E
    Maserati, R
    Mongiovetti, M
    Nasti, G
    Fasan, M
    Vigan, MG
    Bottura, P
    Mena, M
    Pan, A
    Demichieli, A
    Chieppa, F
    Bertelli, D
    Accurso, V
    Di Gennaro, GP
    Schioppa, O
    Tirelli, U
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (03) : A22 - A22
  • [4] Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy
    Palmieri, C.
    Dhillon, T.
    Thirlwell, C.
    Newsom-Davis, T.
    Young, A-M
    Nelson, M.
    Gazzard, B. G.
    Bower, M.
    [J]. HIV MEDICINE, 2006, 7 (05) : 291 - 293
  • [5] Treatment of Kaposi sarcoma in the highly active antiretroviral therapy era
    Dupin, N.
    Del Giudice, P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (03) : 418 - 420
  • [6] Highly active antiretroviral therapy (HAART) and regression of epidemic pulmonary Kaposi's sarcoma.
    Aboulafia, DM
    [J]. BLOOD, 1997, 90 (10) : 2931 - 2931
  • [7] Response of cutaneous AIDS-Kaposi sarcoma (KS) to highly active antiretroviral treatment (HAART) alone
    Paparizos, VA
    Kyriakis, KP
    Botsi, CA
    Papastamopoulos, V
    Hadjivassiliou, M
    Stavrianeas, NG
    Katsambas, AD
    [J]. AIDS, 2000, 14 : S135 - S135
  • [8] Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
    El Amari, Emmanuelle Boffi
    Toutous-Trellu, Laurence
    Gayet-Ageron, Angele
    Baumann, Michele
    Cathomas, Gieri
    Steffan, Ingrid
    Erb, Peter
    Mueller, Nicolas J.
    Furrer, Hansjakob
    Cavassini, Matthias
    Vernazza, Pietro
    Hirsch, Hans H.
    Bernasconi, Enos
    Hirschel, Bernard
    [J]. AIDS, 2008, 22 (09) : 1019 - 1028
  • [9] Kaposi's sarcoma associated with highly active antiretroviral therapy
    Crane, HM
    Deubner, H
    Huang, JC
    Swanson, PE
    Harrington, RD
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (08) : 583 - 583
  • [10] Progressive Pulmonary Kaposi's Sarcoma in the Setting of Highly Active Antiretroviral Therapy (HAART) Compliance: A Case Report
    Hom, K.
    Padgett, J.
    Guo, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345